abrdn Life Sciences Investors (HQL) Options Positioning, Max Pain & Unusual Sweeps

$18.74 +2.52% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

abrdn Life Sciences Investors (HQL) carries a Roarable Rating of D+ (Sell) with 56/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ • SELL / AVOID Cap $481.2M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
RQD QUANT TACHOMETERSELL / AVOID • D+
025507510056
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk C
Cash (11)Whales (10)SEC (13)Macro (13)CEO (9)
Each axis scored 0–20
12M PRICE TARGET CONE-0.9% Base Target
$24 Bull$19 Base$14 Bear
📬 FREE HQL RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HQL)Realized 20D OHLCV Swing Band: ±6.1%
CALL VS. PUT WHALE SHARE
— (No Active Options Snapshot)
Put/Call Ratio: — (No Active Options Snapshot)
MAX-PAIN EXPIRATION MAGNET
— (No Active Options Snapshot)
No active options chain max-pain snapshot on file
HISTORICAL 20D VOLATILITY SWING
±6.1%
Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (HQL)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for HQL.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring HQL)

  • ✓Walkthrough of HQL's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
HQL // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +7.09%📐 HORIZONTAL RANGE
2026-10-30O $18.77H $18.77L $18.25C $18.74VOL 86.5K
RES: $25.13SUP: $16.16SMA50: $19.11SMA200: $18.24
$23.13$21.21$19.28$17.36$15.43RES $25.13SUP $16.16$18.742026-04-302026-06-152026-07-312026-09-162026-10-30
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HQL Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on HQL today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HQL. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for HQL today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HQL)

Financials Rank #680 of 1096 ⚔️ FTHY vs HQL Full Matrix →

1. Head-to-Head Financials Peer Comparison (HQL vs. FTHY, TYG, ETO, NOAH)

Industry: Investment Managers (79 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, abrdn Life Sciences Investors (HQL) ranks #680 by composite RQD confidence (56/100, grade D+) and #715 by equity capitalization ($481.2M). Within this direct 5-issuer industry benchmark cohort, NOAH leads on earnings valuation at 5.8x trailing P/E, while NOAH leads on capital efficiency and profitability with 11.2% ROIC and — gross margin. NOAH currently holds the highest overall quantitative score in the immediate peer group at 64/100 (C) compared with HQL at 56/100 (D+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
HQL ACTIVE
abrdn Life Sciences Investors
D+ 56/100 — — — +2.52% $481.2M Benchmark Subject
FTHY
First Trust High Yield Opportunities 2027 Term Fund
C- 59/100 — — — +0.54% $481.7M /fthy-vs-hql →
TYG
Tortoise Energy Infrastructure Corporation
C- 60/100 — — — +4.15% $479.0M /tyg-vs-hql →
ETO
Eaton Vance Tax-Advantage Global Dividend Opp
C- 59/100 — — — +0.03% $492.8M /eto-vs-hql →
NOAH
Noah Holdings Limited
C 64/100 5.8x — 11.2% 0.00% $462.0M /noah-vs-hql →

2. HQL Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

abrdn Life Sciences Investors (HQL) operates in Investment Managers (Financials) with an equity capitalization of $481.2M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. HQL Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HQL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, abrdn Life Sciences Investors (NYSE: HQL) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 56/100 at a spot price of $18.74 (+2.52% 1D, market cap $481.2M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 9/20. Across 1096 tracked Financials issuers, HQL ranks #680 in composite RQD confidence.

How does HQL compare to FTHY and TYG in the Financials sector?

Within the Financials sector (Investment Managers), HQL carries a Roarable D+ (56/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, FTHY (First Trust High Yield Opportunities 2027 Term Fund) holds a C- grade (59/100 RQD, P/E N/A, ROIC —, cap $481.7M) and TYG (Tortoise Energy Infrastructure Corporation) posts a C- grade (60/100 RQD, P/E N/A, ROIC —, cap $479.0M). Among the 5-stock peer group, NOAH leads on earnings multiple (5.8x) while NOAH leads on capital efficiency (11.2% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HQL?

For abrdn Life Sciences Investors (HQL), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity. and sector rank #680 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and implied 5-year growth hurdle of 8.0%/yr. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HQL trading relative to its 50-day, 200-day, and 52-week technical levels?

HQL last traded at $18.74 (+2.52% on volume of 102,871 shares), positioning the stock -1.94% below its 50-day simple moving average ($19.11) and +2.74% above its 200-day simple moving average ($18.24). Across its 52-week range of $15.66 to $22.67, HQL sits at the 43.9% percentile with a 14-day RSI of 53.0 (NEUTRAL RANGE) and an implied next-earnings move of ±6.1% ($17.60 to $19.88).

HQL Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is HQL's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for HQL.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $213.66 -0.80% AAPL $348.91 +1.48% MSFT $530.14 -0.16% TSLA $403.30 -0.23% PLTR $196.42 -0.20% SOFI $17.61 +2.74% IBIT $43.36 -0.94% GLD $355.78 -1.34%